Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

September 15, 2020
Open Access

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells

Roberta SommaggioAntonio Rosato
September 16, 2020
Open Access

Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism

Eunae Sandra ChoJong In Yook
September 15, 2020
Open Access

Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Haochen YuHaoyu Ren
September 16, 2020
Open Access

Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer

Journal of Geriatric Oncology
Antonis ValachisJohan Ahlgren
September 18, 2020

Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer

Breast Cancer Research and Treatment
Lei XueSao Jiralerspong
September 15, 2020
Open Access

Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer

JAMA Network Open
Oluwadamilola T OladeruSung Jun Ma
September 16, 2020
Open Access

Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma

BMC Women's Health
Harshima Disvini WijesingheMenaka Dilani Samarawickrama Lokuhetty
September 16, 2020

Pembrolizumab in the preoperative setting of triple-negative breast cancer: safety and efficacy

Expert Review of Anticancer Therapy
Romualdo Barroso-Sousa, Sara M Tolaney
September 14, 2020

Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer

Experimental Cell Research
Sheikh Mohammad UmarChandra Prakash Prasad
September 17, 2020

Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature

The American Journal of Case Reports
Xavier CarrierAlexander Philipovskiy
September 18, 2020

Studying the Metabolism of Epithelial-Mesenchymal Plasticity Using the Seahorse XFe96 Extracellular Flux Analyzer

Methods in Molecular Biology
Sugandha BhatiaJennifer H Gunter
September 15, 2020
Open Access

Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers

JCO Precision Oncology
Tess O'MearaLajos Pusztai

Sign up to follow this feed and discover related papers.

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Inflammatory Breast Neoplasms

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

© 2020 Meta ULC. All rights reserved